Related Experiment Videos
Studies on the behavioral and biochemical effects of hemicholinium in vivo
Insights
Hemicholinium (HC-3) causes behavioral changes in rats by depleting brain acetylcholine (ACh). This effect is dose-dependent, supporting HC-3
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Hemicholinium (HC-3) is known to induce behavioral alterations in rats.
- These behavioral changes are associated with a reduction in brain acetylcholine (ACh) levels.
Purpose of the Study:
- To investigate the relationship between Hemicholinium (HC-3) dosage and its effects on brain acetylcholine (ACh) levels and behavior in rats.
- To elucidate the mechanism of action of HC-3 in vivo, specifically its impact on choline uptake.
Main Methods:
- Intraventricular (i.vt.) administration of varying doses of HC-3 to rats.
- Measurement of brain HC-3 concentrations and ACh levels at different time points.
- Assessment of choline (Ch) uptake into subcellular fractions and synaptosomal preparations.
Main Results:
- HC-3 induced a dose-dependent decrease in brain ACh levels and corresponding behavioral changes, with maximal effects at 1 microgram i.vt.
- HC-3 brain concentrations plateaued above 10 microgram i.vt. and correlated with ACh depletion.
- HC-3 did not inhibit choline uptake in disrupted synaptosomal preparations, suggesting its action is not solely on high-affinity choline uptake in intact terminals.
Conclusions:
- The depletion of brain ACh by HC-3 is directly linked to observed behavioral effects in rats.
- The mechanism of HC-3 action in vivo is consistent with the inhibition of high-affinity choline uptake at the cholinergic nerve terminal.
Abstract:
Hemicholinium (HC-3) causes a behavioral reactivity in rats which is correlated with the depletion of brain acetylcholine (ACh). The decrease in ACh levels and behavioral effects caused by HC-3 are correlated in a dose-dependent manner, maximal effects being achieved at an intraventricular (i.vt.) dose of 1 microgram. The HC-3 concentration in the brain 2 hr after i.vt. injection does not increase further with doses greater than 10 microgram. HC-3 (i.vt.) does not affect the uptake of choline (Ch) into subcellular fractions prepared from treated animals. ACh depletion in the brain areas studied closely parallels the HC-3 distribution. HC-3 pretreatment results in greater effects on newly synthesized than on stored ACh. Utilizing a concentration equal to that found in brain after an in vivo dose, HC-3 does not inhibit the uptake of Ch in synaptosomal preparations in which the neuronal membrane was disrupted with ether. The commonly accepted mechanism of action of HC-3, i.e., an inhibition of high affinity Ch uptake at the cholinergic nerve terminal, appears to provide a satisfactory explanation of its effects in vivo.